Efficacy of Replacing Linezolid with OTB-658 in Anti-Tuberculosis Regimens in Murine Models
Antimicrobial Agents and Chemotherapy · 2023
DOI: 10.1128/aac.01399-22 ↗Kurz gefasst
Fachartikel in der Zeitschrift Antimicrobial Agents and Chemotherapy, 2023. Verfasst von Haiting Liu und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, Beijing Key Laboratory of Drug Resistance Tuberculosis Research, Beijing Chest Hospital, Capital Medical University, Beij…. Hauptthemen laut MEDLINE: Mycobacterium tuberculosis, Oxazolidinones, Tuberculosis, Multidrug-Resistant, Extensively Drug-Resistant Tuberculosis. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Beijing Hospitals Authority Clinical Medicine Development of Special Founding Support, National Natural Science Foundation of China.
Abstract (Originalsprache)
Linezolid (LZD) was the first oxazolidinone approved for treating drug-resistant tuberculosis. A newly approved regimen combining LZD with bedaquiline (BDQ) and pretomanid (PMD) (BPaL regimen) is the first 6-month oral regimen that is effective against multidrug- and extensively drug-resistant tuberculosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacology, Beijing Key Laboratory of Drug Resistance Tuberculosis Research, Beijing Chest Hospital, Capital Medical University, Beijing Tuberculosis and Thoracic Tumor Research Institute, Beijing, Peopl…
ORCID-Profile: Yu Lu
Förderung
- Beijing Hospitals Authority Clinical Medicine Development of Special Founding Support
- National Natural Science Foundation of China
Zitieren
APA
Liu, H., Zhu, H., Fu, L., Zhang, W., Chen, X., Wang, B., Guo, S., Ding, Y., Wang, N., Li, D., & Lu, Y. (2023). Efficacy of Replacing Linezolid with OTB-658 in Anti-Tuberculosis Regimens in Murine Models. Antimicrobial Agents and Chemotherapy. https://doi.org/10.1128/aac.01399-22
Vancouver
Liu H, Zhu H, Fu L, Zhang W, Chen X, Wang B, et al. Efficacy of Replacing Linezolid with OTB-658 in Anti-Tuberculosis Regimens in Murine Models. Antimicrobial Agents and Chemotherapy. 2023. doi:10.1128/aac.01399-22
BibTeX
@article{Liu2023,
author = {Liu, Haiting and Zhu, Hui and Fu, Lei and Zhang, Weiyan and Chen, Xi and Wang, Bin and Guo, Shaochen and Ding, Yangming and Wang, Ning and Li, Dongshuo and Lu, Yu},
title = {Efficacy of Replacing Linezolid with OTB-658 in Anti-Tuberculosis Regimens in Murine Models},
journal = {Antimicrobial Agents and Chemotherapy},
year = {2023},
doi = {10.1128/aac.01399-22}
}
EUVIMED